Cytomegalovirus-vectored vaccines for HIV and other pathogens

被引:10
作者
Barry, Peter A. [1 ,2 ,3 ]
Deere, Jesse D. [1 ,2 ,3 ]
Yue, Yujuan [2 ]
Chang, William W. L. [1 ,2 ,3 ]
Schmidt, Kimberli A. [2 ]
Wussow, Felix [6 ]
Chiuppesi, Flavia [6 ]
Diamond, Don J. [6 ]
Sparger, Ellen E. [4 ]
Walter, Mark R. [7 ]
Hartigan-O'Connor, Dennis J. [3 ,5 ]
机构
[1] Univ Calif Davis, Dept Pathol & Lab Med, Davis, CA 95616 USA
[2] Univ Calif Davis, Ctr Immunol & Infect Dis, Davis, CA 95616 USA
[3] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA
[4] Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA
[5] Univ Calif Davis, Dept Microbiol & Immunol, Sch Med, Davis, CA 95616 USA
[6] City Of Hope, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA USA
[7] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA
关键词
AIDS; cytomegalovirus; cytomegalovirus vaccine vector; HIV; nonhuman primate; monkey model; rhesus; rhesus cytomegalovirus; simian immunodeficiency virus; unconventional T-cell responses; MAJOR HISTOCOMPATIBILITY COMPLEX; CHEMOKINE RECEPTOR US28; CD8(+) T-CELLS; MHC CLASS-I; MITOCHONDRIA-LOCALIZED INHIBITOR; SIMIAN IMMUNODEFICIENCY VIRUS; RHESUS CYTOMEGALOVIRUS; HLA-E; VIRAL INTERLEUKIN-10; SURFACE EXPRESSION;
D O I
10.1097/QAD.0000000000002396
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The use of cytomegalovirus (CMV) as a vaccine vector to express antigens against multiple infectious diseases, including simian immunodeficiency virus, Ebola virus, plasmodium, and mycobacterium tuberculosis, in rhesus macaques has generated extraordinary levels of protective immunity against subsequent pathogenic challenge. Moreover, the mechanisms of immune protection have altered paradigms about viral vector-mediated immunity against ectopically expressed vaccine antigens. Further optimization of CMV-vectored vaccines, particularly as this approach moves to human clinical trials will be augmented by a more complete understanding of how CMV engenders mechanisms of immune protection. This review summarizes the particulars of the specific CMV vaccine vector that has been used to date (rhesus CMV strain 68-1) in relation to CMV natural history.
引用
收藏
页码:335 / 349
页数:15
相关论文
共 165 条
  • [1] Major human cytomegalovirus structural protein pp65 (ppUL83) prevents interferon response factor 3 activation in the interferon response
    Abate, DA
    Watanabe, S
    Mocarski, ES
    [J]. JOURNAL OF VIROLOGY, 2004, 78 (20) : 10995 - 11006
  • [2] A heterologous DNA prime/protein boost immunization strategy for rhesus cytomegalovirus
    Abel, Kristina
    Strelow, Lisa
    Yue, Yujuan
    Eberhardt, Meghan K.
    Schmidt, Kimberli A.
    Barry, Peter A.
    [J]. VACCINE, 2008, 26 (47) : 6013 - 6025
  • [3] The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP
    Ahn, K
    Gruhler, A
    Galocha, B
    Jones, TR
    Wiertz, EJHJ
    Ploegh, HL
    Peterson, PA
    Yang, Y
    Fruh, K
    [J]. IMMUNITY, 1997, 6 (05) : 613 - 621
  • [4] Human cytomegalovirus inhibits antigen presentation by a sequential multistep process
    Ahn, KS
    Angulo, A
    Ghazal, P
    Peterson, PA
    Yang, Y
    Fruh, K
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (20) : 10990 - 10995
  • [5] Two novel spliced genes in human cytomegalovirus
    Akter, P
    Cunningham, C
    McSharry, BP
    Dolan, A
    Addison, C
    Dargan, DJ
    Hassan-Walker, AF
    Emery, VC
    Griffiths, PD
    Wilkinson, GWG
    Davison, AJ
    [J]. JOURNAL OF GENERAL VIROLOGY, 2003, 84 : 1117 - 1122
  • [6] Ligand-selective small molecule modulators of the constitutively active vGPCR US28
    Amarandi, Roxana-Maria
    Luckmann, Michael
    Melynis, Motiejus
    Jakobsen, Mette H.
    Fallah, Zohreh
    Spiess, Katja
    Hjorto, Gertrud M.
    Pui, Aurel
    Frimurer, Thomas M.
    Rosenkilde, Mette M.
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 155 : 244 - 254
  • [7] Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus
    Arnon, TI
    Achdout, H
    Levi, O
    Markel, G
    Saleh, N
    Katz, G
    Gazit, R
    Gonen-Gross, T
    Hanna, J
    Nahari, E
    Porgador, A
    Honigman, A
    Plachter, B
    Mevorach, D
    Wolf, DG
    Mandelboim, O
    [J]. NATURE IMMUNOLOGY, 2005, 6 (05) : 515 - 523
  • [8] ASHER DM, 1974, P SOC EXP BIOL MED, V145, P794
  • [9] Patterns of Acute Rhesus Cytomegalovirus (RhCMV) Infection Predict Long-Term RhCMV Infection
    Assaf, Basel T.
    Mansfield, Keith G.
    Westmoreland, Susan V.
    Kaur, Amitinder
    Oxford, Kristie L.
    Diamond, Don J.
    Barry, Peter A.
    [J]. JOURNAL OF VIROLOGY, 2012, 86 (11) : 6354 - 6357
  • [10] Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcγ receptor homologs
    Atalay, R
    Zimmermann, Z
    Wagner, M
    Borst, E
    Benz, C
    Messerle, M
    Hengel, H
    [J]. JOURNAL OF VIROLOGY, 2002, 76 (17) : 8596 - 8608